Epidemiology and Health10.4178/epih/e2012002201234e2012002Persistent Organic Pollutants and Obesity-Related Metabolic Dysfunction: Focusing on Type 2 DiabetesDuk-Hee Lee,
Canadian Journal of Diabetes10.1016/j.jcjd.2015.01.012201539S2Persistent Organic Pollutants: Emerging Factors for Obesity and Type 2 Diabetes Prevalence?Pascal Imbeault,
Journal of Diabetes Investigation10.1111/j.2040-1124.2010.00043.x201014121-122Persistent organic pollutants and epidemic of diabetes and metabolic syndromeHong Kyu Lee,
Diabetes Research and Clinical Practice10.1016/s0168-8227(16)30902-02016120S11Are persistent organic pollutants a common soil of type 2 diabetes and type 3 diabetes (dementia)?Duk-Hee Lee,
Obesity10.1002/oby.2119520152391740-1740Trunk fat and persistent organic pollutantsAngelo Tremblay,
Diabetology & Metabolic Syndrome10.1186/s13098-015-0031-6201571Persistent organic pollutants as risk factors for type 2 diabetesElvis Ndonwi Ngwa, Andre-Pascal Kengne, Barbara Tiedeu-Atogho, Edith-Pascale Mofo-Mato, Eugene Sobngwi,,,
Environment International10.1016/j.envint.2014.12.00120157657-70Association of persistent organic pollutants and non-persistent pesticides with diabetes and diabetes-related health outcomes in Asia: A systematic reviewLindsay M. Jaacks, Lisa R. Staimez,
Current Diabetes Reports10.1007/s11892-017-0966-020171712Persistent Organic Pollutants as Risk Factors for Obesity and DiabetesChunxue Yang, Alice Pik Shan Kong, Zongwei Cai, Arthur C.K. Chung,,
Persistent Organic Pollutants10.5772/intechopen.824652019Introductory Chapter: Persistent Organic Pollutants (POPs)Stephen Kudom Donyinah
Chemico-Biological Interactions10.1016/j.cbi.2022.1101412022366110141GATA3 as an immunomodulator in obesity-related metabolic dysfunction associated with fatty liver disease, insulin resistance, and type 2 diabetesAmr Ahmed El-Arabey, Mohnad Abdalla,